Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 231 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2784 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OXYCODONE CR 40MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-02 2023-08-12 193614
APO-SIMVASTATIN 40MG TABLET Resolved 2023-06-23 2023-07-21 196309
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-07-27 2023-08-12 200194
APO-ROSUVASTATIN 40MG TABLET Resolved 2023-08-23 2023-09-01 202827
APO-SIMVASTATIN 40MG TABLET Resolved 2023-09-07 2024-03-01 203834
APO-ATOMOXETINE 40MG CAPSULE Resolved 2023-09-15 2023-12-01 204411
APO-ATOMOXETINE 40MG CAPSULE Resolved 2023-10-06 2023-12-01 206566
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-10-06 2023-11-06 206573
APO-SIMVASTATIN 40MG TABLET Resolved 2023-10-06 2023-12-01 206576
APO-ESOMEPRAZOLE 40MG TABLET (DELAYED-RELEASE) Resolved 2023-11-10 2023-12-08 209951
APO-NADOLOL 40MG TABLET Resolved 2023-11-17 2024-01-26 210715
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2023-12-01 2023-12-22 212374
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2024-01-05 2024-01-12 215207
APO-OLMESARTAN 40MG TABLET Anticipated shortage 2024-01-19 2024-01-19 216714
APO-ATORVASTATIN 40MG TABLET Resolved 2024-02-02 2024-03-22 218373
APO-PRAVASTATIN 40MG TABLET Resolved 2024-02-02 2024-04-12 218397
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Resolved 2024-02-02 2024-03-15 218403
APO-SIMVASTATIN 40MG TABLET Resolved 2024-02-23 2024-04-05 220462
APO-PRAVASTATIN 40MG TABLET Resolved 2024-03-22 2024-04-12 223064
APO-DOXYCYCLINE MR 40MG CAPSULE (IMMEDIATE AND DELAYED RELEASE) Actual shortage 2024-04-19 2024-05-10 225796

Showing 2141 to 2160 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-ATORVASTATIN 10MG TABLET To be discontinued 2018-09-07 2018-09-07 60276
APO-CYCLOBENZAPRINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60405
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60443
APO-DONEPEZIL 10MG TABLET Discontinued 2018-09-07 2018-09-15 60447
APO-ENALAPRIL 10MG TABLET Discontinued 2018-09-07 2018-12-05 60462
APO-ESCITALOPRAM 10MG TABLET Discontinued 2018-09-07 2018-11-16 60474
APO-LISINOPRIL 10MG TABLET Discontinued 2018-09-07 2019-02-02 60579
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-OXAZEPAM 10MG TABLET Discontinued 2018-09-08 2019-08-30 60675
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-RABEPRAZOLE 10MG TABLET (ENTERIC-COATED) Discontinued 2019-01-04 2019-01-04 71204
APO-AMITRIPTYLINE 10MG TABLET Discontinued 2019-01-04 2019-01-04 71348
APO-SOLIFENACIN 10MG TABLET Discontinued 2019-03-11 2019-09-20 78269
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-09-07 2018-11-02 60597
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146

Showing 81 to 100 of 356